For Surgeons
CartiONE_Knee_Zoom

Benefits

  • SINGLE SURGERY open/close

      • Cell Mix is prepared in one hour thanks to our patented Rapid Chondrocyte Isolation
      • No second implantation surgery required (in contrast to traditional ACI)
      • No cell culturing
  • YOUR OWN NON-CULTURED CHONDROCYTES open/close

      • Non-cultured chondrocytes are not exposed to laboratory culturing conditions which reduce the potential of chondrocytes to produce hyaline cartilage.
      • Your own cells: no risk of disease transfer or rejection
  • CARTIONE CELL MIX FOR A MORE EFFECTIVE CARTILAGE PRODUCTION. open/close

      • Chondrocytes are mixed with cells from the bone marrow
      • The cell combination boosts cartilage production 
      • No external growth factors required

The CartiONE Cell Service is completed entirely within the operating theatre during a single surgical procedure

How it works

Collect cartilage debridement and take biopsy from less-load-bearing area.
STEP 1

Collect cartilage debridement and take biopsy from less-load-bearing area.

Collect bone-marrow biopsy.
STEP 2

Collect bone-marrow biopsy.

CartiONE Technician isolates, counts, and mixes the two cell types.
STEP 3

CartiONE Technician isolates, counts, and mixes the two cell types.

Cell mixture is given to the surgeon for application on carrier of choice.
STEP 4

Cell mixture is given to the surgeon for application on carrier of choice.

Carrier and cell mixture are implanted in the lesion.
STEP 5

Carrier and cell mixture are implanted in the lesion.

Collect cartilage debridement and take biopsy from less-load-bearing area.
STEP 1

Collect cartilage debridement and take biopsy from less-load-bearing area.

Collect bone-marrow biopsy.
STEP 2

Collect bone-marrow biopsy.

CartiONE Technician isolates, counts, and mixes the two cell types.
STEP 3

CartiONE Technician isolates, counts, and mixes the two cell types.

Cell mixture is given to the surgeon for application on carrier of choice.
STEP 4

Cell mixture is given to the surgeon for application on carrier of choice.

Carrier and cell mixture are implanted in the lesion.
STEP 5

Carrier and cell mixture are implanted in the lesion.

CartiONE has been developed in conjunction with the world’s leading joint preservation surgeons.

Clinical outcomes of the first 40 patients treated with CartiONE within the INSTRUCT trial were published in The American Journal of Sports Medicine in May 2020.

CartiONE is ideal for 18–50-year-old skeletally mature patients with focal chondral lesions of the knee of ICRS grades 2 or 3.

It is very important to follow a well-designed rehabilitation program with a professional physiotherapist in order to guarantee proper rehabilitation of the operated knee.

CartiONE
CartiONE

CartiONE is available for dedicated clinics in Europe and Middle East.

Joint Preservation
Solutions for
Orthopaedics

With CartiONE, we have developed an unique joint preservation solution for orthopaedic/sports medicine surgeons that encourage a patient’s own natural healing process. CartiONE offers an innovative regenerative medicine approach to soft tissue defects in joints for patients suffering from injury or cartilage degeneration.